%0 Journal Article
%T Effect of Abdominoplasty in the Lipid Profile of Patients with Dyslipidemia
%A Guillermo Ramos-Gallardo
%A Ana P¨¦rez Verdin
%A Miguel Fuentes
%A Sergio God¨ªnez Guti¨¦rrez
%A Ana Rosa Ambriz-Plascencia
%A Ignacio Gonz¨¢lez-Garc¨ªa
%A Sonia Mericia G¨®mez-Fonseca
%A Rosalio Madrigal
%A Luis Iv¨¢n Gonz¨¢lez-Reynoso
%A Sandra Figueroa
%A Xavier Toscano Igartua
%A D¨¦ctor Francisco Jim¨¦nez Gutierrez
%J Plastic Surgery International
%D 2013
%I Hindawi Publishing Corporation
%R 10.1155/2013/861348
%X Introduction. Dyslipidemia like other chronic degenerative diseases is pandemic in Latin America and around the world. A lot of patients asking for body contouring surgery can be sick without knowing it. Objective. Observe the lipid profile of patients with dyslipidemia, before and three months after an abdominoplasty. Methods. Patients candidate to an abdominoplasty without morbid obesity were followed before and three months after the surgery. We compared the lipid profile, glucose, insulin, and HOMA (cardiovascular risk marker) before and three months after the surgery. We used Student's test to compare the results. A value less than 0.05 was considered as significant. Results. Twenty-six patients were observed before and after the surgery. At the third month, we found only statistical differences in LDL and triglyceride values ( 0.04 and 0.03). The rest of metabolic values did not reach statistical significance. Conclusion. In this group of patients with dyslipidemia, at the third month, only LDL and triglyceride values reached statistical significances. There is no significant change in glucose, insulin, HOMA, cholesterol, VLDL, or HDL. 1. Introduction Dyslipidemia is a silent pandemic affecting millions of people around the world. There is more than one factor predisposing this serious problem, where not only diet, exercise, and medications could solve it [1]. The truth is that a lot of people can be sick without knowing it. There is controversy of the possible benefit of liposuction or abdominoplasty in the metabolism of glucose or cholesterol. There are no reports about the effect of abdominoplasty in the metabolism of patients with dyslipidemia. 2. Objectives Observe any possible change in the lipid profile, weight, cardiovascular risk markers (HOMA), glucose, or insulin of patients with dyslipidemia after an abdominoplasty. 3. Methods A descriptive observational study was designed to follow up the lipid profile of patients with dyslipidemia candidates to a body contouring surgery as abdominoplasty. The research project was evaluated and approved by the ethics and research committee of the Antiguo Hospital Civil de Guadalajara (file number in the institution 112-11). The ethics and research committee evaluated all the research projects in the decentralized, academic, and public Antiguo Hospital Civil de Guadalajara. It follows the guidelines according to the Health Mexican Norm and the Helsinki ethical principles. Abdominoplasty or lipoabdominoplasty is offered to women to improve the body images in case of severe skin laxity, excess fat, and
%U http://www.hindawi.com/journals/psi/2013/861348/